Status:

COMPLETED

Influence of Respiratory Mechanics on Diaphragmatic Dysfunction in COPD Patients Who Have Failed NIV (RHYDIAN)

Lead Sponsor:

University of Modena and Reggio Emilia

Conditions:

Diaphragm Dysfunction

COPD Exacerbation

Eligibility:

All Genders

18+ years

Brief Summary

Although non-invasive mechanical ventilation (NIV) is the gold standard treatment for patients with acute exacerbation of COPD (AECOPD) who develop respiratory acidosis, failure rate are still high ra...

Eligibility Criteria

Inclusion

  • age over 18 years
  • AECOPD with respiratory acidosis admitted to the Respiratory Intensive Care Unit of the University Hospital of Modena (Italy) undergoing endotracheal intubation due to NIV failure.

Exclusion

  • history of neuromuscular disease,
  • presence of chest wall deformities,
  • coexistence of interstitial lung disease,
  • presence of pulmonary edema,
  • severe hemodynamic instability,
  • septic shock,
  • evidence of lobar pneumonia or bilateral parenchymal consolidation at chest X-ray on admission,
  • contraindication to NIV,
  • previously assessed diaphragmatic palsy,
  • intracranial hypertension,
  • known pregnancy,
  • need for immediate endotracheal intubation,
  • neurologic impairment,
  • lack of collaboration,
  • unreliable maneuver to calculate maximal transdiaphragmatic pressure.

Key Trial Info

Start Date :

January 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2022

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT03852394

Start Date

January 1 2017

End Date

March 1 2022

Last Update

April 7 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital of Modena Policlinico di Modena

Modena, Italy